Allergan to sell FDA-approved Restasis in first multi-dose bottle

Restasis MultiDose will now be available and approved by the U.S. Food and Drug Administration for help treating patients with a type of Chronic Dry Eye by helping them make more of their own tears.
The product becomes the first and only FDA-approved preservative-free medication eye drop sold in a multi-dose bottle.
"Since Restasis MultiDose is the only FDA-approved, preservative-free prescription eye drop in the U.S. to be offered in a multidose bottle, patients now have a choice of a multidose bottle or single-use vials," Dr. Neda Shamie of Advanced Vision Care in Los Angeles said in a statement.
Allergan noted that Restasis Multidose, which is designed with new and patented air filter technology, will be available for the same price of single-use vials. Additionally, the product helps the environment by using less plastic.
"We are continuously looking to improve patient care through state-of-the-art product engineering, and Restasis MultiDose reflects that commitment," David Nicholson, chief R&D officer at Allergan, said. "This new multi-dose bottle is designed to maintain the preservative-free formulation."